On the Bid is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week.

In this edition, host Christina Morrissy discusses key changes in conditions for the healthcare sector and the companies benefiting post-Covid. 

Christina chats with Grady Wulff, market analyst at Bell Direct. 

Wulff joined Bell Direct as a market analyst in August 2022. Her role is to provide in-depth market insights and analysis to identify trading and investment opportunities for Bell Direct’s clients.

The pair take a look companies making waves in the Healthcare sector.

Telix Pharmaceuticals (ASX:TLX) is a global, commercial-stage biopharmaceutical company focused on the development of diagnostic and therapeutic (‘theranostic’) products using targeted radiation.

Volpara Health Technologies (ASX:VHT) makes software to save families from cancer. Healthcare providers use Volpara to better understand cancer risk, empower patients in personal care decisions, and guide recommendations about additional imaging, genetic testing, and other interventions.

Monash IVF Group (ASX:MVF) is a driving force in the development of assisted reproductive technologies (ART) and tertiary level prenatal diagnostics.

Nanosonics (ASX:NAN) is an Australian infection prevention company that has successfully developed and commercialised a unique automated disinfection technology, the trophon® device.

PolyNovo (ASX:PNV) PolyNovo develops innovative medical devices utilising the patented bioabsorbable polymer technology Novosorb®.

The panel discuss a range of topics including a 2023 relief rally across the markets, the conditions of the healthcare sector post-Covid, local and global growing momentum, Grady’s healthcare stock picks and more.

So click above to tune in!